4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-24-003447
Options or other derivatives
- CSO and Director acquired 43,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Newman Michael James CSO and Director | 2024-01-22 | Grant or award · Stock Option (Right to Buy) | +43,250 | 43,250 | D | ||
Loading xslF345X05/ownership.xml…